No Data
No Data
Express News | Checkpoint Therapeutics Announces FDA Approval of Unloxcyt™ (Cosibelimab-Ipdl)
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT (Cosibelimab-ipdl)
Fortress Solutions Names Dan Lakey as Chief Revenue Officer to Drive Strategic Growth and Strengthen FortressONE Platform
Press Release: Fortress Acquires Infra Pipe Solutions, Leading Manufacturer of HDPE Pipes and Structures
A. G. P. Maintains Fortress Biotech(FBIO.US) With Buy Rating, Cuts Target Price to $4
HC Wainwright & Co. Maintains Buy on Fortress Biotech, Raises Price Target to $26